Status not kept up to date
Robotic Transanal Specimen Extraction Surgery Versus Robotic Transabdominal Incision Specimen Extraction Surgery for Patients With Rectal Cancer: A Multicenter Randomized Controlled Trial
NCT05468944 · Taiyuan Li · Updated 21 July 2022
- What is being tested
- Transanal specimen extraction robotic surgery; Transabdominal specimen extraction robotic surgery
- For
- Rectal Neoplasms; Robotic Surgery; Natural Orifice Specimen Extraction Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 556 people. The full rules are on the registry page.
- Where
- China (12 sites)
- When
- Starts or started Jan 2023, ends Dec 2025. Registered 21 July 2022.
- Results
- None posted yet.
In the researchers' words
This prospective, multicenter, randomized, open-label study aims to evaluate the perioperative safety and feasibility of specimen extraction through anus regarding robotic radical excision of rectal cancer.
Sites
- Cancer Institute and Hospital, Chinese Academy of Medical SciencesBeijing, China
- The Second Xiangya Hospital, Central South UniversityChangsha, China
- Three Gorges Hospital Affiliated to Chongqing UniversityChongqing, China
- Fujian Cancer HospitalFuzhou, China
- The First Affiliated Hospital of Gannan Medical UniversityGanzhou, China
- The Second Affiliated Hospital, Sun Yat-sen UniversityGuangzhou, China
- The Second Affiliated Hospital of Harbin Medical UniversityHarbin, China
- The First Affiliated Hospital of Nanchang UniversityNanchang, China
- Zhongshan Hospital, Fudan UniversityShanghai, China
- The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an, China
- Zhongshan Hospital of Xiamen UniversityXiamen, China
- The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, China